SUMMARY Nerve excitability is useful for prognosis in Bell's palsy. Minimal excitability values (MEV) were obtained by stimulating the facial nerve and recording the effective current (mA) required to evoke a minimal visible contraction of frontalis, orbicularis oculi, orbicularis oris, and mentalis muscles respectively. Serial MEVs were performed on 100 patients with facial palsy, of whom 87 were followed for six months or to complete recovery; 61 patients were treated with steroids of whom 57 had good recovery. Serial MEVs were not only useful for prognosis, but also helpful in regulating the dosage of prednisone.
Facial nerve excitability tests (Gilliatt and Taylor, 1959) are used to determine the course of facial nerve dysfunction, and to select patients for surgical decompression. Alford (1967) stated that nerve excitability studies are useful 72 hours after the onset of paralysis. Campbell et al. (1962) , Laumans (1965) , and Leclaire et al. (1975) correlated nerve excitability tests with the rate of recovery. Since prednisone is widely used to treat Bell's palsy, it is important to determine whether serial nerve excitability tests can be used to modify dosage.
Patients and methods
One hundred patients were seen in the three years from 1973 to 1976. All had facial paralysis that was maximal in one or two days. The history or examination indicated that the palsy was complete or nearly complete in all cases. The usual diagnostic tests as suggested by the anatomical and diagnostic reviews of Paine (1957) and Alford et al. (1974) , were performed in order to localise the Supported by a Center Grant from the Muscular Dystrophy Association. Presented In our laboratory, the normal range for MEVs is 2 to 10 mA as determined bilaterally in 15 normal subjects aged 20 to 50 years. This is consistent with values reported in the literature (Laumans, 1965 (Gilliatt and Taylor, 1959; Taverner, 1965) and an evoked potential with an amplitude of 1.0 mV or greater are regarded as normal.
The patients ranged in age from 1 to 77 years (15 under 15 years), and at onset the palsy was usually complete or near complete. In 67 patients the first study was done before the eighth day, and in 11 of these as early as the second day. Another 16 patients were studied from nine to 14 days. Relatively few patients had first MEVs after two weeks. The patients seen by the sixth day after onset received only MEV measurements, and these were repeated twice a week. At this stage at least one-third of the patients required adjustment of the dosage of prednisone. Motor latencies were estimated after the seventh day, and needle electromyography performed to determine the extent of denervation changes approximately one week later. Motor latencies of the facial nerve to frontalis, orbicularis oculi, orbicularis oris, and mentalis muscles were measured on the affected side, and compared with those of the clinically unaffected side. In children or in adults with relatively normal MEVs, and also in patients with clear clinical improvement, electromyography was not performed.
Seventy-eight patients were treated with steroids, usually prednisone, but one patient received dexamethasone. Our standard regimen is to start with 60 mg of prednisone per day for four days as recommended by Adour et al. (1972) , followed by tapering of the dose over the next two to four weeks. This was regarded as adequate therapy. It was modified according to the MEVs in a few cases where the dosage was increased or a higher dosage was maintained for a longer period. In children a dose of 2 mg/kg body weight was given and similarly tapered. In 26 patients inadequate or no steroids were given, usually due to noncompliance with therapy. A contraindication was present in only five of these patients. Diabetes mellitus was not considered to be a contraindication; however, in patients with moderately severe diabetes, a lower dose of prednisone was given.
Results
In 25 patients, the initial MEVs were within the normal range, with less than 2 mA difference between the two sides. A difference of 3 to 5 mA was seen at one or more muscles in 26 patients, and a difference of 6 to 10 mA in another 26 patients. In 23 patients, no response was obtained, or a difference of greater than 10 mA was seen.
Minimal excitability values were increased bilaterally in 28 patients (Table 1) . Of these, only four (Table 3) . In approximately one-third of these patients, prednisone dosage was modified according to the MEVs. In one child aged 14 years, upon noticing the apparent increase in MEV which was also associated with clinical deterioration, a second course of prednisone therapy was instituted which resulted in significant improvement (Table 5) . More commonly, a higher dose of prednisone was maintained for longer periods until a significant improvement in the MEVs was noticed. Most patients are now managed in this way.
Dis-ussion
Sir Charles Bell, in his book The Nervous System of the Human Body (1844), described cases with unilateral facial palsy, including cases secondary (Hunt, 1907; Aitken and Brain, 1933) . Since then, several other viruses have been implicated in the aetiology of Bell's palsy (Saunders, 1963; Grose et al., 1973; Pollack et al., 1975) . Recently, Adour et al. (1975) suggested that Bell's palsy may be caused by reactivation of herpes simplex virus.
Prednisone is now being widely used to treat Bell's palsy (Adour et al., 1972) . Minimal excitability values have been helpful not only in determining the prognosis of Bell's palsy (Leclaire et al., 1975) but in modifying prednisone therapy.
Patients with normal MEVs or with less than 5 mA difference between the two sides, usually recovered completely. Those with a difference of more than 5 mA, usually recovered incompletely, unless the MEVs returned to normal or clearly improved within the first week. When MEVs were persistently abnormal, prednisone therapy was modified. The prognosis was poorest in patients with complete paralysis and who showed no response to stimulation. Recovery was also prolonged when MEVs were increased for longer than one week. Twenty-eight patients had bilaterally increased MEVs, four with bilateral paralysis. However, a higher incidence of bilateral pathology has been reported (Safman, 1971) .
Children and diabetic patients showed slower recovery than normal adults, and often the prednisone had to be adjusted according to the MEV (Table 5 ). In discussion of Lauman's study (1965) , Groves mentioned that, in his experience, quite frequently there was sudden worsening of nerve excitability one or two days before spontaneous recovery of voluntary movement. On careful review, we found no evidence of this phenomenon in our study, and indeed most patients exhibiting a deterioration in nerve excitability had clinical worsening. Adour and Wingerd (1974) also found poor outcome in patients with diabetes mellitus. In patients with severe palsy where a difference in MEV of greater than 5 mA was recorded, it is our clinical impression that prednisone shortened the time of recovery. However, in our unselected cases, comparison of treated and untreated patients indicated that steroid therapy was effective to a degree which was highly significant statistically (5 per 1000 significance level; x2= 11.51; df=2).
Our partial recovery state is essentially a good partial recovery, and in this study we found that 93% (75+18) of steroid-treated patients reached this level and only 73% (38+35) of essentially untreated patients did so. This figure for steroidtreated patients is comparable with the therapeutic results of Adour and Wingerd (1974) .
